Next-Generation Water-Soluble Cannabinoid and/or Terpene Extract System

Publication ID: 24-11857589_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Water-Soluble Cannabinoid and/or Terpene Extract System,” Published Technical Disclosure No. 24-11857589_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857589_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,589.

Summary of the Inventive Concept

A futuristic system for personalized, targeted, and efficient delivery of water-soluble cannabinoid and/or terpene extracts, leveraging cutting-edge technologies to revolutionize the industry.

Background and Problem Solved

The original patent introduced a water-soluble, powdered cannabinoid and/or terpene extract, but it has limitations in terms of bioavailability, customization, and targeted delivery. The new inventive concept addresses these limitations by incorporating bioavailability enhancers, genetic profiling, nano-particle delivery systems, and real-time monitoring, thereby providing a more efficient and effective solution.

Detailed Description of the Inventive Concept

The system comprises a water-soluble, powdered cannabinoid and/or terpene extract, which can be customized based on an individual's genetic profile to optimize the cannabinoid and/or terpene ratio. The extract is then loaded onto a nano-particle delivery system, designed to target specific cells or tissues in the body, increasing the efficacy of the extract. The system also includes a device for administering the extract, such as a dry powder inhaler utilizing a piezoelectric actuator to generate a precise dosage. Furthermore, a wearable device tracks the individual's physiological response to the extract and communicates with a mobile application to adjust the dosage in real-time.

Novelty and Inventive Step

The new claims introduce several novel and non-obvious features, including the use of naturally-derived bioavailability enhancers, genetic profiling for personalized formulations, and real-time monitoring and adjustment of dosage. These advancements make the original patent's concept obsolete, as they provide a more efficient, targeted, and effective solution.

Alternative Embodiments and Variations

Alternative embodiments of the system could include different types of bioavailability enhancers, various methods for genetic profiling, and diverse nano-particle delivery systems. Additionally, the system could be adapted for use in different industries, such as pharmaceuticals, nutraceuticals, or cosmetics.

Potential Commercial Applications and Market

The next-generation water-soluble cannabinoid and/or terpene extract system has vast commercial potential in the pharmaceutical, nutraceutical, and cosmetic industries, offering a more efficient, targeted, and effective solution for delivering cannabinoids and terpenes. The market for such a system is expected to be substantial, driven by the growing demand for personalized and effective healthcare solutions.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K9/107
A A61 A61K47/02
A A61 A61K47/36
A A61 A61K47/40
A A61 A61K47/44

Field of Art

Pharmaceutical and nutraceutical formulation technologies, specifically cannabinoid extract preparation, drug delivery systems, and personalized medicine with a focus on advanced powder processing and bioavailability enhancement

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or related fields, possessing expertise in drug formulation, nanotechnology, and personalized medicine techniques, with working knowledge of cannabinoid extraction and delivery methodologies

Obviousness Rationale

A PHOSITA would recognize that the PTD represents predictable extensions of the source patent's core technology, applying known techniques in personalized medicine, nanotechnology, and drug delivery to enhance the original water-soluble cannabinoid extract concept. The variations represent logical combinations of existing technologies that would be apparent to someone skilled in pharmaceutical formulation and drug delivery systems. The incremental improvements in targeting, personalization, and administration are consistent with standard innovation practices in pharmaceutical technology.

Obvious Combinations & Variations

Source Patent Element
Water-soluble, micronized cannabinoid extract complexed with cyclodextrin
PTD Variation
Nano-particle delivery system targeting specific cells or tissues
Obviousness Reasoning
Predictable application of known nanotechnology techniques to improve drug targeting, representing a standard approach in pharmaceutical formulation for enhanced bioavailability
Source Patent Element
Powdered extract emulsified with maltodextrin and acacia
PTD Variation
Naturally-derived bioavailability enhancers increasing absorption rate by at least 20%
Obviousness Reasoning
Routine optimization of existing formulation techniques, using known principles of pharmaceutical excipient selection to improve extract performance
Source Patent Element
Water-soluble powdered cannabis extract
PTD Variation
Personalized extract formulation based on individual genetic profiling
Obviousness Reasoning
Logical extension of personalized medicine approaches, applying standard genetic analysis techniques to cannabinoid extract customization
Source Patent Element
Mesoporous silica loading technique
PTD Variation
Piezoelectric actuator-based dry powder inhaler for precise dosage administration
Obviousness Reasoning
Predictable combination of known drug delivery technologies, representing a standard engineering approach to improving medication administration
Source Patent Element
Cannabinoid extract powder with adjustable bulk density
PTD Variation
Real-time physiological monitoring and dosage adjustment via wearable device
Obviousness Reasoning
Obvious application of contemporary digital health monitoring technologies to pharmaceutical delivery, representing a standard approach in personalized medicine
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, when viewed in light of US Patent 11857589. The incremental technological improvements represent predictable combinations of known techniques in pharmaceutical formulation, nanotechnology, and personalized medicine, thus rendering potential patent claims covering similar technologies unpatentable as obvious variations of the prior art.

Original Patent Information

Patent NumberUS 11,857,589
TitleWater-soluble, powdered cannabinoid and/or terpene extract
Assignee(s)MEDPHARM HOLDINGS, LLC